2 Medical News
- №466 в категории «Здоровье»
- №7 691 среди международных каналов
- №10 644 среди каналов на языке «английский»
- №11 869 в мире
Every Day, 2 Medical News from the most Trusted Journals https://2medical.news Aldo Lorenzetti M.D, Internal Medicine & Hepatology, Milano - SIMEDET Delegate
- 24 часа
- 0
- 7 дней
- –
- 30 дней
- –
- Реакции
- 0
- Репосты
- –
- Комментарии
- –
Динамика подписчиков
Подписчиков у канала «2 Medical News»: 348. Средний охват поста за сутки около 3, вовлечённость 0,9 %.
По дням, последние 30 дней
| Дата | Подписчики | Изменение | Посты | Ср. просмотры поста |
|---|---|---|---|---|
| 12 ноя | 348 | 0 | 0 | – |
| 11 ноя | 348 | 0 | 1 | 3 |
| 10 ноя | 348 | 0 | 1 | 4 |
| 9 ноя | 348 | −1 | 1 | 6 |
| 19 окт | 349 | – | 1 | 22 |
Просмотры по возрасту поста
Средние просмотры в каждом возрасте, посты за последние 30 дней.
- 7 дней
- 10
Когда публикует
Время по UTC. 23 поста за 90 дней.
Последние посты
-
Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association https://2medical.news/2026/11/11/caffeine-and-cardiovascular-disease-a-scientific-statement-from-the-american-heart-association/
3 просмотров -
Global health outcomes from replacing dietary sodium chloride with potassium-enriched salt https://2medical.news/2026/11/10/global-health-outcomes-from-replacing-dietary-sodium-chloride-with-potassium-enriched-salt/
4 просмотров -
Responsiveness of epigenetic aging biomarkers to longevity interventions in humans https://2medical.news/2026/11/09/responsiveness-of-epigenetic-aging-biomarkers-to-longevity-interventions-in-humans/
6 просмотров -
Development and Validation of a Machine Learning Model for Predicting Three-Month Unplanned Readmission in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study https://2medical.news/2026/11/06/development-and-validation-of-a-machine-learning-model-for-predicting-three-month-unplanned-readmission-in-patients-with-moderate-to-severe-chronic-obstructive-pulmonary-disease-a-retrospective-cohor/
11 просмотров -
Correlation between serum uric acid-to-creatinine ratio and diabetic retinopathy in type 2 diabetes mellitus patients https://2medical.news/2026/11/05/correlation-between-serum-uric-acid-to-creatinine-ratio-and-diabetic-retinopathy-in-type-2-diabetes-mellitus-patients/
10 просмотров -
Lower serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA-glomerulonephritis https://2medical.news/2026/11/04/lower-serum-c3-levels-are-associated-with-glomerulosclerosis-in-membranous-nephropathy-and-anca-glomerulonephritis/
9 просмотров -
Stage 1 Registered Report: sex differences in anticoagulation and stroke outcomes among patients with atrial fibrillation: a registry-based cohort study https://2medical.news/2026/11/03/stage-1-registered-report-sex-differences-in-anticoagulation-and-stroke-outcomes-among-patients-with-atrial-fibrillation-a-registry-based-cohort-study/
10 просмотров -
Severe Rhabdomyolysis With Minimal Muscular Symptoms After Long-Term Rosuvastatin Use: A Case Report and Brief Literature Review https://2medical.news/2026/11/02/severe-rhabdomyolysis-with-minimal-muscular-symptoms-after-long-term-rosuvastatin-use-a-case-report-and-brief-literature-review/
14 просмотров -
Artificial intelligence in myeloproliferative neoplasms: From digital bone marrow pathology to clinical decision support https://2medical.news/2026/10/30/artificial-intelligence-in-myeloproliferative-neoplasms-from-digital-bone-marrow-pathology-to-clinical-decision-support/
21 просмотров -
In-Hospital and One-Year Outcomes After Percutaneous Coronary Intervention for Chronic Coronary Occlusion in Octogenarians https://2medical.news/2026/10/29/in-hospital-and-one-year-outcomes-after-percutaneous-coronary-intervention-for-chronic-coronary-occlusion-in-octogenarians/
17 просмотров
-
Metabolic Dysfunction-Associated Fatty Liver Disease-Cardiovascular-Kidney-Metabolic (MAFLD-CKM): A Modified Framework to Predict Long-Term Mortality https://2medical.news/2026/10/19/metabolic-dysfunction-associated-fatty-liver-disease-cardiovascular-kidney-metabolic-mafld-ckm-a-modified-framework-to-predict-long-term-mortality/
22 просмотров -
Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program https://2medical.news/2026/10/16/effectiveness-and-safety-of-three-years-of-bulevirtide-monotherapy-in-patients-with-hdv-related-compensated-cirrhosis-the-italian-compassionate-use-program/
21 просмотров -
Relationship between vitamin D serum concentration and inflammatory bowel disease demographics: A cross-sectional study https://2medical.news/2026/10/20/relationship-between-vitamin-d-serum-concentration-and-inflammatory-bowel-disease-demographics-a-cross-sectional-study/
21 просмотров -
Artificial intelligence in myeloproliferative neoplasms: From digital bone marrow pathology to clinical decision support https://2medical.news/2026/10/30/artificial-intelligence-in-myeloproliferative-neoplasms-from-digital-bone-marrow-pathology-to-clinical-decision-support/
21 просмотров -
The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica https://2medical.news/2026/10/18/the-2026-british-society-for-rheumatology-guideline-for-the-treatment-of-polymyalgia-rheumatica/
20 просмотров -
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Risk of Retinal Vascular Occlusions https://2medical.news/2026/10/22/the-impact-of-glucagon-like-peptide-1-receptor-agonists-on-risk-of-retinal-vascular-occlusions/
18 просмотров -
Impact of preoperative osteoporosis on short- and long-term complications following ankle ORIF: A multi-institutional propensity-matched analysis https://2medical.news/2026/10/17/impact-of-preoperative-osteoporosis-on-short-and-long-term-complications-following-ankle-orif-a-multi-institutional-propensity-matched-analysis/
18 просмотров -
In-Hospital and One-Year Outcomes After Percutaneous Coronary Intervention for Chronic Coronary Occlusion in Octogenarians https://2medical.news/2026/10/29/in-hospital-and-one-year-outcomes-after-percutaneous-coronary-intervention-for-chronic-coronary-occlusion-in-octogenarians/
17 просмотров -
Oral vs parenteral drug administration: Quantifying the future health costs of routine prescribing choices through their environmental scope https://2medical.news/2026/10/23/oral-vs-parenteral-drug-administration-quantifying-the-future-health-costs-of-routine-prescribing-choices-through-their-environmental-scope/
17 просмотров -
Psychosocial Factors Associated with Diabetes Distress Among Adults with Type 2 Diabetes Mellitus: The Roles of Perceived Social Support and Diabetes Management Self-Efficacy in an Indonesian Outpatient Sample https://2medical.news/2026/10/21/psychosocial-factors-associated-with-diabetes-distress-among-adults-with-type-2-diabetes-mellitus-the-roles-of-perceived-social-support-and-diabetes-management-self-efficacy-in-an-indonesian-outpatie/
16 просмотров
Вопросы о канале «2 Medical News»
Сколько подписчиков у канала «2 Medical News»?
У канала «2 Medical News» (@mednewstoday) 348 подписчиков на 12 ноября 2026 г.
Сколько человек видят пост в канале «2 Medical News»?
Средний пост набирает около 3 просмотров за 24 часа, это примерно 1 % подписчиков (ERR).
О чём канал «2 Medical News»?
Канал в категории «Здоровье», язык постов: английский. Описание канала: «Every Day, 2 Medical News from the most Trusted Journals https://2medical.news Aldo Lorenzetti M.D, Internal Medicine & Hepatology, Milano - SIMEDET Delegate»
Какое место занимает канал «2 Medical News»?
По числу подписчиков: №466 в категории «Здоровье», №7 691 среди международных каналов, №10 644 среди каналов на языке «английский», №11 869 в мире.
Публикует ли канал «2 Medical News» рекламу?
За последние 30 дней ни один из 23 постов не помечен как реклама (#ad, Sponsored, «Реклама»). Рекламу без пометки определить нельзя.
Когда публикует канал «2 Medical News»?
Пик публикаций: понедельник, около 08:00 по UTC. Выходит около 5 постов в неделю.
Статистика обновлена 1 час назад.